ValuEngine Upgrades Prana Biotechnology (PRAN) to “Hold”
Prana Biotechnology (NASDAQ:PRAN) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday. Separately, B. Riley set a $4.00 target price on Prana Biotechnology and gave the stock a “buy” rating in a …